跳至主要内容
临床试验/NCT02104401
NCT02104401已完成1 期

Pilot Study: Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood

Georgetown University2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Improvement of Motor and Speech Symptoms of Parkinson's Disease or Related Disorders

研究概览

简要总结

This research will help us to understand whether transcranial direct current stimulation (tDCS) can safely improve recovery of speech and language abilities, gait , and mood in people with Parkinson's disease and related disorders. Some of the disorders that will be studied to understand if tDCS can be useful include Parkinson's Disease, Multi-System Atrophy (MSA) and progressive supranuclear palsy (PSP).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Parkinson's disease or a related disorder (e.g. Multiple Systems Atrophy) as diagnosed by a neurologist specializing in Movement Disorders
  • Age >= 18 years

排除标准

  • Skull defect at or near site of tDCS delivery.
  • History of a significant stroke or traumatic brain injury.
  • History of other brain conditions that could impact interpretation of results (such as MS, brain tumor, encephalitis).
  • Presence of implanted electrical or metallic devices in the head or body (examples include cardiac pacemakers or defibrillators, Baclofen pumps, deep brain stimulators, ventricular shunts with metallic parts, vagus nerve stimulators)
  • Presence of ferrous metal in the head (except titanium; for instance shrapnel)
  • History of psychiatric disease requiring hospitalization, electroconvulsive therapy, or ongoing medication use (other than common antidepressants)
  • Pregnancy

结局指标

主要结局

Improvement of Motor and Speech Symptoms of Parkinson's Disease or Related Disorders

时间窗: 16 weeks

We will perform an assessment of motor function using Part III of the Unified Parkinson's Disease Rating Scale (UPDRS), timed test of gait, and patient self-assessment. Speech functions will be assessed with sentence repetition,evaluation of spontaneous speech, and other standard language tests. The assessment will also include other measures and questionnaires (e.g. Bech Depression Inventory) to be filled out by the patient and his/her family.

次要结局

  • Improvement of Neuropsychiatric Symptoms of Parkinson's Disease or Related Disorders(16 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Open Label Treatment With tDCS for Parkinson's and... | 临床试验